Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹7.1 LQualified Make: PEGNEX
Model: 6MG/0.05ML
Title: Inj Brolucizumab For Intravitreal B 6 JANPATH COMPLEX SANDEEP PHARMACEUTICALS B 6 JANPATH COMPLEX NEAR BINDAL PUL CHAKROTA ROAD DEHRADUN DEHRADUN DEHRADUN UTTARAKHAND 248001 UDYAM UK 05 0002014 | DEHRADUN | UTTARAKHAND | 248001 | Make: PEGNEX
Model: 6MG/0.05ML
Title: Inj Brolucizumab For Intravitreal | L1 | Qualified |
Tender Value
Refer Docs
EMD Value
₹15,000
Closing Date
18 Nov 2023, 10:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Inj Brolucizumab for Intravitreal 6 mg/0.05 ml (Q3)
5503201
GEM/2023/B/4124206
Two Packet Bid
Inj Brolucizumab for Intravitreal 6 mg/0.05 ml
90 days
Uttarakhand; Dehradun
Total value wise evaluation
PRODUCT_CUSTOM
6 documents required · 6 mandatory
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Inj Brolucizumab for Intravitreal 6 mg/0.05 ml (Q3) | DEHRADUN | 30 | 90 days |
₹15,000
4 Dec 2023
28 Oct 2023
18 Nov 2023
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5503201.pdf
GEM_BID
inj_brolucizumab_2023-10-23-10-11-17_623810fd07e55a79e3c2e1be7750968a.pdf
SPECIFICATION
1698040837.pdf
OTHER
Undertking_a922a4fd-0124-449a-af6c1698041567192_hempreet@1234.docx
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .